Arbutus Biopharma Corp · Sales/Maturities of Investments

Latest reported$103.11Mperiod endingJun 30, 2026

ABUS Sales/Maturities of Investments ($10.26M → $103.11M)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

ABUS sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	155,277,000
Dec 31, 2024	164,639,000
Dec 31, 2023	132,270,000
Dec 31, 2022	56,000,000
Dec 31, 2021	70,350,000
Dec 31, 2020	73,398,000
Dec 31, 2019	87,675,000
Dec 31, 2018	0
Dec 31, 2017	35,086,000
Dec 31, 2016	0
Dec 31, 2015	9,645,000
Dec 31, 2014	0
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	5,472,740
Dec 31, 2008	2,141,866
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	3,936,552
Dec 31, 2003	17,810,844
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	10,262,307